Literature DB >> 1973246

Emergence of mefloquine-resistant malaria in Africa without drug pressure.

P Brasseur, J Kouamouo, R S Moyou, P Druilhe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 1973246     DOI： 10.1016/0140-6736(90)91578-x

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  9 in total

1.  Pfmdr1 alleles and response to ultralow-dose mefloquine treatment in Gabonese patients.

Authors:  Denise P Mawili-Mboumba; Jürgen F J Kun; Bertrand Lell; Peter G Kremsner; Francine Ntoumi
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

2.  A primary malarial infection is composed of a very wide range of genetically diverse but related parasites.

Authors:  P Druilhe; P Daubersies; J Patarapotikul; C Gentil; L Chene; T Chongsuphajaisiddhi; S Mellouk; G Langsley
Journal:  J Clin Invest       Date:  1998-05-01       Impact factor: 14.808

3.  Chemotherapy of drug-resistant malaria.

Authors:  K C Kain
Journal:  Can J Infect Dis       Date:  1996-01

Review 4.  Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  K J Palmer; S M Holliday; R N Brogden
Journal:  Drugs       Date:  1993-03       Impact factor: 9.546

5.  In vitro monitoring of Plasmodium falciparum drug resistance in French Guiana: a synopsis of continuous assessment from 1994 to 2005.

Authors:  Eric Legrand; Béatrice Volney; Jean-Baptiste Meynard; Odile Mercereau-Puijalon; Philippe Esterre
Journal:  Antimicrob Agents Chemother       Date:  2007-10-22       Impact factor: 5.191

Review 6.  Combination therapy for malaria: the way forward?

Authors:  François Nosten; Philippe Brasseur
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 7.  Halofantrine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic potential.

Authors:  H M Bryson; K L Goa
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

8.  Ex-vivo Sensitivity of Plasmodium falciparum to Common Anti-malarial Drugs: The Case of Kéniéroba, a Malaria Endemic Village in Mali.

Authors:  Karim Traoré; Seidina A S Diakité; Sekou Bah; Drissa S Konaté; Djeneba Dabitao; Ibrahim Sanogo; Modibo Sangaré; Souleymane Dama; Bourama Keita; Mory Doumbouya; Merepen A Guindo; Seydou Doumbia; Mahamadou Diakité
Journal:  Drugs R D       Date:  2020-09

9.  A SYBR Green 1-based in vitro test of susceptibility of Ghanaian Plasmodium falciparum clinical isolates to a panel of anti-malarial drugs.

Authors:  Neils B Quashie; Nancy O Duah; Benjamin Abuaku; Lydia Quaye; Ruth Ayanful-Torgby; George A Akwoviah; Margaret Kweku; Jacob D Johnson; Naomi W Lucchi; Venkatachalam Udhayakumar; Christopher Duplessis; Karl C Kronmann; Kwadwo A Koram
Journal:  Malar J       Date:  2013-12-17       Impact factor: 2.979
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.